Profund Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
TGY2IT
Profund Advisors's VKTX Position: Q3 2026 in Review
Profund Advisors increased its Viking Therapeutics (VKTX) stake by 4.2% in Q3 2026, buying an estimated $71.1K and bringing the position to 50,459 shares worth $1.64M. The position accounts for 0.05% of the portfolio, ranked #245.
Profund Advisors first reported a position in VKTX in Q1 2023 and has held it in 15 quarters since. The position peaked at $3.16M in Q2 2024. 197 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Profund Advisors held 50,459 shares of Viking Therapeutics worth $1.64M as of Q3 2026.
- Profund Advisors bought 2,052 Viking Therapeutics shares in Q3 2026, an estimated $71.1K.
- Viking Therapeutics made up 0.05% of Profund Advisors's portfolio in Q3 2026, its #245 holding.
- Profund Advisors first reported a position in Viking Therapeutics in Q1 2023 and has held it in 15 quarters since.
- Profund Advisors's Viking Therapeutics position peaked at $3.16M in Q2 2024.
- 197 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.